BCAR1 antibody (AA 275-325)
Quick Overview for BCAR1 antibody (AA 275-325) (ABIN2617497)
Target
See all BCAR1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 275-325
-
Brand
- IHC-plus™
-
Specificity
- Region between residue 275 and 325 of human breast cancer anti-estrogen resistance 1 (Crk-associated substrate p130Cas) using the numbering given in entry NP_055382.2 (GeneID 9564).
-
Purification
- Immunoaffinity purified
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Approved: IF (1:50 - 1:500), IHC, IHC-P (1:100)
Usage: Immunohistochemistry: Antigen retrieval is recommended. Antigen retrieval with citrate buffer will enhance staining. Likely to work with frozen sections. In some cases, the antibody may be diluted further than indicated. Human controls: Breast Carcinoma, Colon Carcinoma, Ovarian Carcinoma, Prostate Carcinoma, Stomach Adenocarcinoma. Mouse controls: Teratoma. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Tris-buffered saline, 0.1 % BSA, 0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store at 2-8°C for up to 1 year.
-
Expiry Date
- 12 months
-
-
- BCAR1 (Breast Cancer Anti-Estrogen Resistance 1 (BCAR1))
-
Alternative Name
- BCAR1 / p130Cas
-
Background
-
Name/Gene ID: BCAR1
Synonyms: BCAR1, CAS, CAS1, CRKAS, CASS1, CRK-associated substrate, p130Cas -
Gene ID
- 9564
-
Pathways
- EGFR Signaling Pathway, Neurotrophin Signaling Pathway, CXCR4-mediated Signaling Events, Platelet-derived growth Factor Receptor Signaling
Target
-